Science Explorer Back to mapMap
Discussion
Company · Nantes · France

InFlectis BioScience

inflectisbioscience.comROR OpenAlex
Research works
4
▼ 44% vs 2018-21
Citations
44
11.5 per fractional work
Top-10% rate
9.8%
all institutions 10.0%
Open access
65%
world 40%
International
29%
world 18%
InFlectis BioScience

Not ranked overall: InFlectis BioScience is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does InFlectis BioScience work in?

In all years, 49% of research at InFlectis BioScience is in Life Sciences, 46% in Health Sciences. Its largest fields are Medicine (46%), Biochemistry, Genetics and Molecular Biology (23%), Neuroscience (15%). It does 1.4× the world's share of Life Sciences.

Life Sciences: 2 fractional works · 48.7% of its workBiochemistry, Genetics and Molecular Biology: 1 fractional works · 23.1% of its workNeuroscience: 1 fractional works · 15.4% of its workImmunology and Microbiology: 0 fractional works · 10.3% of its workHealth Sciences: 2 fractional works · 46.2% of its workMedicine: 2 fractional works · 46.2% of its workPhysical Sciences: 0 fractional works · 5.1% of its workChemistry: 0 fractional works · 2.6% of its workEngineering: 0 fractional works · 2.6% of its workALL ITS WORKInFlectisBioScience4fractional works, all years
Life Sciences49%Physical Sciences5%Health Sciences46%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 6 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology123.1%
    2. Neuroscience115.4%
    3. Immunology and Microbiology010.3%
    1. Medicine246.2%
    1. Chemistry02.6%
    2. Engineering02.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from InFlectis BioScience?

The most cited paper from InFlectis BioScience is "Control of the Unfolded Protein Response in Health and Disease" (Dimitrios Doultsinos, Tony Avril, Stéphanie Lhomond et al., 2017), with 75 citations. Next come "The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial" (63) and "Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice" (42).

Most cited papers
#PaperReleasedCitations
1 Control of the Unfolded Protein Response in Health and Disease Dimitrios Doultsinos, Tony Avril, Stéphanie Lhomond et al. · SLAS DISCOVERY Open access 26 May 2017 75
2 The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial Eleonora Dalla Bella et al. · Brain Open access 23 Apr 2021 63
3 Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice Yunhong Bai, Caroline Treins, Vera G. Volpi et al. · Molecular Neurobiology Open access 30 Apr 2022 42
4 Pharmacological modulation of the ER stress response ameliorates oculopharyngeal muscular dystrophy Alberto Malerba, Fanny Roth, Pradeep Harish et al. · Human Molecular Genetics Open access 12 Jan 2019 34
5 An O-GlcNAcylomic Approach Reveals ACLY as a Potential Target in Sepsis in the Young Rat Manon Denis et al. · International Journal of Molecular Sciences Open access 26 Aug 2021 21
All 20 most cited papers, with filters and sorting

Which research topics does InFlectis BioScience publish most on?

By volume in 2022-now: Immune cells in cancer, Endoplasmic Reticulum Stress and Disease, Cancer Immunotherapy and Biomarkers and Inflammatory Biomarkers in Disease Prognosis.

Immune cells in cancer0Immune cells in cancer: 0 fractional worksEndoplasmic Reticulum St…0Endoplasmic Reticulum Stress and Disease: 0 fractional worksCancer Immunotherapy and…0Cancer Immunotherapy and Biomarkers: 0 fractional worksInflammatory Biomarkers …0Inflammatory Biomarkers in Disease Prognosis: 0 fractional worksGenetic Neurodegenerativ…0Genetic Neurodegenerative Diseases: 0 fractional worksAmyotrophic Lateral Sclerosis Research: 0 fractional worksHereditary Neurological Disorders: 0 fractional worksMechanical Circulatory Support Devices: 0 fractional worksParkinson's Disease Mechanisms and Treatments: 0 fractional worksNeurogenetic and Muscular Disorders Research: 0 fractional works
ImmunologyCell BiologyOncologyCellular and Molecular Neuroscience3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Immune cells in cancer Immunology 0 works
  2. 2 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 0 works
  4. 4 Inflammatory Biomarkers in Disease Prognosis Oncology 0 works
  5. 5 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  6. 6 Amyotrophic Lateral Sclerosis Research Neurology 0 works
  7. 7 Hereditary Neurological Disorders Cellular and Molecular Neuroscience 0 works
  8. 8 Mechanical Circulatory Support Devices Biomedical Engineering 0 works
  9. 9 Parkinson's Disease Mechanisms and Treatments Neurology 0 works
  10. 10 Neurogenetic and Muscular Disorders Research Genetics 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available64.9%not open35.1%

World: 40% of research is openly available.

with international co-authors28.9%domestic only71.1%

World: 18% is written across borders.

How has InFlectis BioScience's research output changed?

Output in 2022-2025 was 44% lower than in 2018-2021.

still counting20202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Nantes

All research institutions in Nantes

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about InFlectis BioScience. Posts are plain text and can be reported.